Enhancement of GLP-2 activity of suppressing appetite

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S308000

Reexamination Certificate

active

07862824

ABSTRACT:
The effects of GLP-2 are enhanced using a GLP-1 activity inhibitor. For medical use to treat or inhibit the onset of medical conditions, disorder or diseases for which treatment with GLP-2 is indicated, the present invention provides a pharmaceutical combination comprising a GLP-2 activity enhancer, and a GLP-1 activity inhibitor. The combination is useful particularly to treat gastrointestinal conditions such as small bowel syndrome, mucositis and Crohn's disease, and to suppress appetite, for instance to treat obesity.

REFERENCES:
patent: 5789379 (1998-08-01), Drucker et al.
patent: 5912229 (1999-06-01), Thim et al.
patent: 6573291 (2003-06-01), Gronberg et al.
patent: WO02/066062 (2002-08-01), None
Tang-Christensen et al., “The Proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake”, Nature America, Inc. -, Nature Medicine, Jul. 2000, vol. 6, pp. 802-807.
Lovshin et al., “Glugan-like Peptide (GLP-2) Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling”, The Journal of Biological Chemistry, Jun. 2001, vol. 276, No. 24, pp. 21489-21499.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Enhancement of GLP-2 activity of suppressing appetite does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancement of GLP-2 activity of suppressing appetite, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of GLP-2 activity of suppressing appetite will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2656916

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.